Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

ASP Isotopes (ASPI) Financials

ASP Isotopes logo
$9.35 +0.32 (+3.54%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$9.36 +0.01 (+0.11%)
As of 08/22/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for ASP Isotopes

Annual Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -4.95 -16 -35
Consolidated Net Income / (Loss)		 -4.95 -16 -32
Net Income / (Loss) Continuing Operations		 -4.95 -16 -32
Total Pre-Tax Income 		-4.95 -16 -32
Total Operating Income		 -5.10 -16 -26
Total Gross Profit		 0.00 0.14 1.60
Total Revenue		 0.00 0.43 4.14
Operating Revenue		 0.00 0.43 4.14
Total Cost of Revenue		 0.00 0.29 2.54
Operating Cost of Revenue		 0.00 0.29 2.54
Total Operating Expenses		 5.10 16 28
Selling, General & Admin Expense		 3.83 15 25
Research & Development Expense		 1.27 0.76 3.14
Total Other Income / (Expense), net		 0.15 -0.26 -5.96
Interest Expense		 0.00 0.12 0.26
Interest & Investment Income		 0.00 0.01 1.24
Other Income / (Expense), net		 0.15 -0.15 -6.94
Income Tax Expense		 0.00 -0.01 0.11
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 -0.01 -0.09
Basic Earnings per Share		 - ($0.49) ($0.63)
Weighted Average Basic Shares Outstanding		 26.79M 33.07M 55.67M
Diluted Earnings per Share		 - ($0.49) ($0.63)
Weighted Average Diluted Shares Outstanding		 26.79M 33.07M 55.67M
Weighted Average Basic & Diluted Shares Outstanding		 26.79M 33.07M 72.07M

Quarterly Income Statements for ASP Isotopes

This table shows ASP Isotopes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.81 - -3.62 -4.29 -4.22 -4.16 -6.95 -12 -7.27 -9.18 -8.45
Consolidated Net Income / (Loss)		 -3.91 - -3.62 -4.29 -4.22 -4.17 -6.96 -8.88 -7.36 -9.22 -8.46
Net Income / (Loss) Continuing Operations		 -3.91 - -3.62 -4.29 -4.22 -4.17 -6.96 -8.88 -7.36 -9.13 -8.46
Total Pre-Tax Income 		-3.91 - -3.62 -4.29 -4.22 -4.18 -7.01 -8.87 -7.36 -9.07 -8.53
Total Operating Income		 -1.95 - -3.72 -4.35 -3.95 -4.02 -5.81 -7.46 -5.43 -7.65 -7.95
Total Gross Profit		 0.00 - 0.00 0.00 0.00 0.14 0.28 0.42 0.29 0.61 0.33
Total Revenue		 0.00 - 0.00 0.00 0.00 0.43 0.84 1.02 1.09 1.19 1.10
Operating Revenue		 - - 0.00 0.00 0.00 0.43 0.84 1.02 1.09 1.19 1.10
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 0.29 0.56 0.60 0.79 0.59 0.77
Operating Cost of Revenue		 - - 0.00 0.00 0.00 0.29 0.56 0.60 0.79 0.59 0.77
Total Operating Expenses		 3.91 - 3.72 4.35 3.95 4.16 6.09 7.88 5.73 8.25 8.28
Selling, General & Admin Expense		 1.21 - 3.52 4.09 3.71 4.10 5.88 7.41 4.69 6.84 6.75
Research & Development Expense		 0.75 - 0.21 0.25 0.24 0.07 0.22 0.47 1.03 1.42 1.53
Total Other Income / (Expense), net		 -0.00 - 0.11 0.06 -0.28 -0.15 -1.20 -1.41 -1.93 -1.42 -0.58
Interest Expense		 - - 0.00 0.00 0.00 0.12 0.01 0.07 0.09 0.09 0.09
Interest & Investment Income		 0.00 - 0.00 0.00 0.00 0.00 0.01 0.04 0.60 0.58 0.51
Other Income / (Expense), net		 -0.00 - 0.11 0.06 -0.28 -0.04 -1.20 -1.38 -2.44 -1.92 -1.01
Income Tax Expense		 - - 0.00 0.00 0.00 -0.01 -0.05 0.01 -0.01 0.06 -0.07
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - 0.00 0.00 0.00 -0.01 -0.02 0.05 -0.08 -0.04 -0.02
Basic Earnings per Share		 ($0.06) - - - ($0.14) - ($0.16) - ($0.12) - ($0.12)
Weighted Average Basic Shares Outstanding		 30.11M 26.79M 29.14M 29.80M 31.15M 33.07M 44.56M 66.69M 61.53M 55.67M 69.48M
Diluted Earnings per Share		 ($0.06) - - - ($0.14) - ($0.16) - ($0.12) - ($0.12)
Weighted Average Diluted Shares Outstanding		 - 26.79M 29.14M 29.80M 31.15M 33.07M 44.56M 66.69M 61.53M 55.67M 69.48M
Weighted Average Basic & Diluted Shares Outstanding		 - 26.79M 29.14M 29.80M 31.15M 33.07M 44.56M 49.14M 71.39M 72.07M 75.06M

Annual Cash Flow Statements for ASP Isotopes

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -0.77 5.52 54
Net Cash From Operating Activities		 -2.94 -5.41 -17
Net Cash From Continuing Operating Activities		 -2.94 -5.41 -17
Net Income / (Loss) Continuing Operations		 -4.95 -16 -32
Consolidated Net Income / (Loss)		 -4.95 -16 -32
Depreciation Expense		 0.00 0.04 0.47
Non-Cash Adjustments To Reconcile Net Income		 1.93 9.58 18
Changes in Operating Assets and Liabilities, net		 0.07 1.26 -2.34
Net Cash From Investing Activities		 -4.47 -2.45 -11
Net Cash From Continuing Investing Activities		 -4.47 -2.45 -11
Purchase of Property, Plant & Equipment		 -4.47 -2.33 -9.68
Acquisitions		 0.00 -0.12 0.00
Other Investing Activities, net		 - 0.00 -1.70
Net Cash From Financing Activities		 6.64 13 83
Net Cash From Continuing Financing Activities		 6.64 13 83
Repayment of Debt		 0.00 -0.70 -0.61
Repurchase of Common Equity		 -1.47 -0.56 -3.65
Issuance of Debt		 0.00 0.53 26
Issuance of Common Equity		 8.12 14 53
Other Financing Activities, net		 -0.01 -0.01 7.27

Quarterly Cash Flow Statements for ASP Isotopes

This table details how cash moves in and out of ASP Isotopes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 - 0.82 2.13 -1.71 -0.47 5.57 16 6.53 23 11 -5.75
Net Cash From Operating Activities		 - -0.86 -1.44 -1.26 -0.65 -2.06 -2.97 -5.12 -4.84 -3.76 -3.17
Net Cash From Continuing Operating Activities		 - -1.80 -2.01 -1.51 0.17 -2.06 -2.97 -0.60 -7.30 -3.76 -3.17
Net Income / (Loss) Continuing Operations		 - -1.30 -3.62 -4.29 -4.22 -4.17 -6.96 -8.88 -7.36 -9.22 -8.46
Consolidated Net Income / (Loss)		 - -1.30 -3.62 -4.29 -4.22 -4.17 -6.96 -8.88 -7.36 -9.22 -8.46
Depreciation Expense		 - - 0.00 0.00 0.00 0.04 0.10 0.15 0.18 0.05 0.15
Non-Cash Adjustments To Reconcile Net Income		 - 0.99 2.14 2.37 2.90 2.16 3.56 5.88 5.91 4.65 3.21
Changes in Operating Assets and Liabilities, net		 - -1.43 -0.55 0.38 1.52 -0.09 0.33 2.36 -6.04 0.76 1.93
Net Cash From Investing Activities		 - -0.90 -0.36 -0.15 -0.68 -1.26 -1.25 -2.62 -4.48 -3.02 -2.36
Net Cash From Continuing Investing Activities		 - -0.90 -0.36 -0.15 -0.68 -1.26 -1.25 -2.62 -4.48 -3.02 -2.36
Purchase of Property, Plant & Equipment		 - -0.90 -0.36 -0.15 -0.68 -1.14 -1.25 -2.62 -4.48 -1.32 -2.31
Other Investing Activities, net		 - - - - - - 0.00 - - - -0.05
Net Cash From Financing Activities		 - 3.79 4.49 - - 8.89 20 12 32 18 -0.23
Net Cash From Continuing Financing Activities		 - 3.79 4.49 - - 8.89 20 12 32 18 -0.23
Repayment of Debt		 - 0.01 0.00 - - -0.70 -0.26 -0.18 - -0.17 -0.25
Issuance of Debt		 - - 0.00 - - 0.53 21 5.39 - 0.50 0.05
Other Financing Activities, net		 - - -0.51 0.51 - -0.01 -0.02 1.48 5.57 0.23 -0.02

Annual Balance Sheets for ASP Isotopes

This table presents ASP Isotopes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 12 28 94
Total Current Assets		 3.30 11 66
Cash & Equivalents		 2.39 7.91 62
Accounts Receivable		 0.00 0.22 0.71
Inventories, net		 - 0.00 0.07
Prepaid Expenses		 0.91 1.66 3.05
Other Current Assets		 0.00 0.72 0.03
Plant, Property, & Equipment, net		 8.20 11 22
Total Noncurrent Assets		 0.99 6.32 6.25
Goodwill		 0.00 3.27 3.17
Noncurrent Deferred & Refundable Income Taxes		 - 0.00 0.03
Other Noncurrent Operating Assets		 0.99 3.05 3.05
Total Liabilities & Shareholders' Equity		 12 28 94
Total Liabilities		 2.68 8.71 43
Total Current Liabilities		 1.94 5.67 7.06
Short-Term Debt		 0.03 0.47 0.94
Accounts Payable		 1.35 1.11 1.02
Accrued Expenses		 0.36 1.31 2.28
Current Deferred Revenue		 0.00 0.88 0.88
Other Current Liabilities		 0.19 1.90 1.94
Total Noncurrent Liabilities		 0.74 3.04 36
Long-Term Debt		 - 0.00 35
Other Noncurrent Operating Liabilities		 0.74 2.93 1.25
Commitments & Contingencies		 - 0.00 0.00
Total Equity & Noncontrolling Interests		 9.82 19 51
Total Preferred & Common Equity		 9.82 16 48
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 9.82 16 48
Common Stock		 17 41 106
Retained Earnings		 -7.55 -24 -56
Accumulated Other Comprehensive Income / (Loss)		 0.26 -0.92 -2.16
Noncontrolling Interest		 0.00 2.53 3.27

Quarterly Balance Sheets for ASP Isotopes

This table presents ASP Isotopes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 12 45 55 84 91
Total Current Assets		 2.73 26 32 56 59
Cash & Equivalents		 2.29 24 28 52 56
Accounts Receivable		 - 0.35 0.52 0.56 0.69
Inventories, net		 - - - 0.08 0.34
Prepaid Expenses		 0.44 1.93 3.25 3.87 2.03
Other Current Assets		 - 0.00 0.05 0.00 0.00
Plant, Property, & Equipment, net		 8.35 14 18 23 25
Total Noncurrent Assets		 0.80 4.85 4.91 5.05 6.47
Goodwill		 - 3.17 3.29 3.46 3.26
Noncurrent Deferred & Refundable Income Taxes		 - - - - 0.11
Other Noncurrent Operating Assets		 0.80 1.68 1.63 1.59 3.09
Total Liabilities & Shareholders' Equity		 12 45 55 84 91
Total Liabilities		 3.23 32 40 42 45
Total Current Liabilities		 2.60 7.33 8.01 7.43 8.18
Short-Term Debt		 0.03 0.21 0.03 0.03 0.77
Accounts Payable		 0.40 2.22 2.43 1.80 2.05
Accrued Expenses		 1.09 1.77 2.46 1.76 3.05
Current Deferred Revenue		 0.88 0.88 0.88 0.88 0.88
Other Current Liabilities		 0.19 2.25 2.21 2.95 1.43
Total Noncurrent Liabilities		 0.63 25 32 35 37
Long-Term Debt		 - 22 29 32 36
Other Noncurrent Operating Liabilities		 0.63 2.95 3.23 2.83 1.11
Commitments & Contingencies		 - - - 0.00 0.00
Total Equity & Noncontrolling Interests		 8.64 13 14 42 46
Total Preferred & Common Equity		 8.64 11 11 39 43
Preferred Stock		 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 8.64 11 11 39 43
Common Stock		 30 43 51 85 108
Retained Earnings		 -20 -31 -40 -47 -65
Accumulated Other Comprehensive Income / (Loss)		 -1.29 -1.46 -0.70 0.60 -0.99
Noncontrolling Interest		 - 2.51 3.35 3.32 3.21

Annual Metrics And Ratios for ASP Isotopes

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 0.00% 0.00% 857.04%
EBITDA Growth		 0.00% -226.43% -103.18%
EBIT Growth		 0.00% -227.18% -105.62%
NOPAT Growth		 0.00% -214.61% -64.28%
Net Income Growth		 0.00% -229.50% -98.98%
EPS Growth		 0.00% 0.00% -28.57%
Operating Cash Flow Growth		 0.00% -84.10% -208.47%
Free Cash Flow Firm Growth		 0.00% 0.00% -102.53%
Invested Capital Growth		 0.00% 52.67% 107.57%
Revenue Q/Q Growth		 0.00% 0.00% 22.49%
EBITDA Q/Q Growth		 0.00% -1,667,112.69% -20.10%
EBIT Q/Q Growth		 0.00% 0.00% -19.80%
NOPAT Q/Q Growth		 0.00% 0.00% -15.95%
Net Income Q/Q Growth		 0.00% 0.00% -18.45%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% -28.34% -11.36%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 3.38%
Invested Capital Q/Q Growth		 0.00% 78.39% 6.28%
Profitability Metrics		 - - -
Gross Margin		 0.00% 32.09% 38.60%
EBITDA Margin		 0.00% -3,730.34% -791.94%
Operating Margin		 0.00% -3,704.63% -635.91%
EBIT Margin		 0.00% -3,738.99% -803.31%
Profit (Net Income) Margin		 0.00% -3,762.85% -782.36%
Tax Burden Percent		 100.00% 99.96% 100.34%
Interest Burden Percent		 99.93% 100.68% 97.06%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -119.11% -105.29%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -15.68% -25.33%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 5.36% 12.65%
Return on Equity (ROE)		 -100.74% -113.75% -92.64%
Cash Return on Invested Capital (CROIC)		 0.00% -160.81% -175.24%
Operating Return on Assets (OROA)		 0.00% -80.88% -54.62%
Return on Assets (ROA)		 0.00% -81.39% -53.20%
Return on Common Equity (ROCE)		 -100.74% -103.69% -84.96%
Return on Equity Simple (ROE_SIMPLE)		 -50.37% -99.99% -67.69%
Net Operating Profit after Tax (NOPAT)		 -3.57 -11 -18
NOPAT Margin		 0.00% -2,593.24% -445.14%
Net Nonoperating Expense Percent (NNEP)		 -58.41% -103.43% -79.96%
Return On Investment Capital (ROIC_SIMPLE)		 - -58.18% -21.57%
Cost of Revenue to Revenue		 0.00% 67.91% 61.40%
SG&A Expenses to Revenue		 0.00% 3,560.15% 598.77%
R&D to Revenue		 0.00% 176.57% 75.74%
Operating Expenses to Revenue		 0.00% 3,736.72% 674.51%
Earnings before Interest and Taxes (EBIT)		 -4.95 -16 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.95 -16 -33
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 5.36 6.75
Price to Tangible Book Value (P/TBV)		 0.00 6.70 7.23
Price to Revenue (P/Rev)		 0.00 201.61 78.04
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 7.23 12.65
Enterprise Value to Revenue (EV/Rev)		 0.00 190.29 72.18
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.03 0.67
Long-Term Debt to Equity		 0.00 0.00 0.65
Financial Leverage		 -0.24 -0.34 -0.50
Leverage Ratio		 1.27 1.40 1.74
Compound Leverage Factor		 1.27 1.41 1.69
Debt to Total Capital		 0.34% 2.44% 40.18%
Short-Term Debt to Total Capital		 0.34% 2.44% 1.10%
Long-Term Debt to Total Capital		 0.00% 0.00% 39.09%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 13.13% 3.82%
Common Equity to Total Capital		 99.66% 84.43% 56.00%
Debt to EBITDA		 -0.01 -0.03 -1.05
Net Debt to EBITDA		 0.48 0.46 0.84
Long-Term Debt to EBITDA		 0.00 0.00 -1.02
Debt to NOPAT		 -0.01 -0.04 -1.86
Net Debt to NOPAT		 0.66 0.66 1.49
Long-Term Debt to NOPAT		 0.00 0.00 -1.81
Altman Z-Score		 0.00 3.09 3.29
Noncontrolling Interest Sharing Ratio		 0.00% 8.85% 8.29%
Liquidity Ratios		 - - -
Current Ratio		 1.71 1.85 9.31
Quick Ratio		 1.23 1.43 8.87
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -15 -31
Operating Cash Flow to CapEx		 -65.72% -232.16% -172.56%
Free Cash Flow to Firm to Interest Expense		 0.00 -127.88 -118.61
Operating Cash Flow to Interest Expense		 0.00 -45.66 -64.49
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -65.32 -101.87
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.02 0.07
Accounts Receivable Turnover		 0.00 0.00 8.98
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.05 0.25
Accounts Payable Turnover		 0.00 0.24 2.39
Days Sales Outstanding (DSO)		 0.00 0.00 40.67
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 1,530.92 152.99
Cash Conversion Cycle (CCC)		 0.00 -1,530.92 -112.33
Capital & Investment Metrics		 - - -
Invested Capital		 7.46 11 24
Invested Capital Turnover		 0.00 0.05 0.24
Increase / (Decrease) in Invested Capital		 0.00 3.93 12
Enterprise Value (EV)		 0.00 82 299
Market Capitalization		 0.00 87 323
Book Value per Share		 $0.37 $0.33 $0.67
Tangible Book Value per Share		 $0.37 $0.27 $0.63
Total Capital		 9.85 19 86
Total Debt		 0.03 0.47 34
Total Long-Term Debt		 0.00 0.00 33
Net Debt		 -2.36 -7.44 -28
Capital Expenditures (CapEx)		 4.47 2.33 9.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.99 -2.60 -2.27
Debt-free Net Working Capital (DFNWC)		 1.40 5.31 60
Net Working Capital (NWC)		 1.37 4.84 59
Net Nonoperating Expense (NNE)		 1.38 5.06 14
Net Nonoperating Obligations (NNO)		 -2.36 -7.44 -28
Total Depreciation and Amortization (D&A)		 0.00 0.04 0.47
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -600.77% -54.67%
Debt-free Net Working Capital to Revenue		 0.00% 1,225.49% 1,438.74%
Net Working Capital to Revenue		 0.00% 1,116.86% 1,416.08%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.63)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 33.07M 55.67M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.63)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 33.07M 55.67M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 33.07M 72.07M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.57 -11 -18
Normalized NOPAT Margin		 0.00% -2,593.24% -445.14%
Pre Tax Income Margin		 0.00% -3,764.27% -779.67%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 -136.58 -128.60
NOPAT to Interest Expense		 0.00 -94.73 -71.26
EBIT Less CapEx to Interest Expense		 0.00 -156.24 -165.98
NOPAT Less CapEx to Interest Expense		 0.00 -114.39 -108.64
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -29.63% -3.46% -11.25%

Quarterly Metrics And Ratios for ASP Isotopes

This table displays calculated financial ratios and metrics derived from ASP Isotopes' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 175.71% 31.09%
EBITDA Growth		 0.00% 0.00% 0.00% 0.00% -115.98% 0.00% -89.22% -103.56% -82.22% -136.43% -27.54%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% -116.02% 0.00% -93.91% -106.23% -86.35% -135.43% -27.78%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% -101.99% 0.00% -56.11% -71.53% -37.68% -90.10% -36.76%
Net Income Growth		 0.00% 0.00% 0.00% 0.00% -7.92% 0.00% -92.66% -107.20% -74.20% -121.12% -21.49%
EPS Growth		 0.00% 0.00% 0.00% 0.00% -133.33% 0.00% 0.00% 0.00% 14.29% 0.00% 25.00%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -138.65% -105.57% -307.72% -640.92% -82.76% -6.72%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -114.98% -161.00% -33.46%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 52.67% 0.00% 0.00% 248.42% 107.57% 132.27%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 94.07% 21.65% 6.40% 9.76% -7.73%
EBITDA Q/Q Growth		 0.00% 100.00% 0.00% -18.71% 1.09% 4.73% -69.15% -27.71% 11.46% -23.62% 7.44%
EBIT Q/Q Growth		 0.00% 100.00% 0.00% -18.59% 1.43% 3.88% -72.60% -26.12% 10.94% -21.44% 6.32%
NOPAT Q/Q Growth		 0.00% 100.00% 0.00% -16.72% 9.22% -1.94% -44.53% -28.25% 27.14% -40.75% -3.98%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% -18.57% 1.49% 1.24% -13,426.27% -27.52% 17.18% -25.36% 8.24%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -67.62% 13.01% 48.03% -214.91% -44.39% -72.52% 5.55% 22.32% 15.69%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 26.26% -128.71% -32.45% 3.76% 10.47% -16.94%
Invested Capital Q/Q Growth		 0.00% 0.00% -100.00% 0.00% 0.00% 78.39% -0.29% 33.96% 46.23% 6.28% 11.58%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 32.09% 33.18% 41.18% 27.03% 50.74% 29.67%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -929.61% -810.25% -850.59% -707.83% -797.18% -799.72%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -929.07% -691.95% -729.48% -499.55% -640.58% -721.89%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -938.03% -834.28% -864.93% -724.01% -801.01% -813.24%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -963.04% -828.80% -868.77% -676.24% -772.36% -768.10%
Tax Burden Percent		 100.07% 0.00% 100.00% 100.00% 100.00% 99.85% 99.32% 100.16% 99.89% 101.69% 99.17%
Interest Burden Percent		 199.85% 0.00% 99.99% 99.97% 99.92% 102.82% 100.02% 100.29% 93.51% 94.82% 95.24%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -29.87% -108.59% -154.06% -82.62% -106.06% -117.95%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -2.22% 238.73% -1,009.54% -50.35% -83.93% -90.39%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.76% -30.54% -60.17% 21.88% 41.92% 32.32%
Return on Equity (ROE)		 0.00% -100.74% 0.00% 0.00% 0.00% -29.11% -139.13% -214.23% -60.74% -64.15% -85.63%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -160.81% -423.45% -395.42% -221.91% -175.24% -185.29%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -20.29% -46.81% -72.52% -51.03% -54.47% -52.59%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -20.83% -46.51% -72.84% -47.67% -52.52% -49.67%
Return on Common Equity (ROCE)		 0.00% -100.74% 0.00% 0.00% 0.00% -26.54% -112.33% -164.26% -56.76% -58.83% -77.29%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -186.77% -220.12% -70.74% 0.00% -79.79%
Net Operating Profit after Tax (NOPAT)		 -1.37 0.00 -2.61 -3.04 -2.76 -2.82 -4.07 -5.22 -3.80 -5.35 -5.57
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -650.35% -484.36% -510.64% -349.69% -448.41% -505.32%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.00% -129.60% -27.65% -347.31% 855.48% -32.27% -22.13% -27.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -14.59% - - - -6.26% -6.76%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 67.91% 66.82% 58.82% 72.97% 49.26% 70.33%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 946.11% 699.53% 724.37% 431.48% 572.71% 612.69%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 15.05% 25.60% 46.30% 95.10% 118.61% 138.87%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 961.16% 725.13% 770.66% 526.58% 691.32% 751.56%
Earnings before Interest and Taxes (EBIT)		 -1.96 0.00 -3.62 -4.29 -4.23 -4.06 -7.01 -8.84 -7.87 -9.56 -8.96
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.96 0.00 -3.60 -4.27 -4.23 -4.03 -6.81 -8.70 -7.70 -9.52 -8.81
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 5.36 19.15 14.38 4.79 6.75 7.95
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 6.70 27.40 20.51 5.26 7.23 8.61
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 201.61 158.19 69.00 54.79 78.04 76.72
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 7.23 17.81 10.69 7.59 12.65 12.20
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 190.29 158.85 70.83 49.93 72.18 73.06
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.03 1.71 2.03 0.76 0.67 0.80
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 1.69 2.03 0.76 0.65 0.78
Financial Leverage		 0.00 -0.24 0.00 0.00 -0.26 -0.34 -0.13 0.06 -0.43 -0.50 -0.36
Leverage Ratio		 0.00 1.27 0.00 0.00 1.37 1.40 3.48 3.81 1.90 1.74 2.32
Compound Leverage Factor		 0.00 0.00 0.00 0.00 1.37 1.44 3.48 3.82 1.77 1.65 2.21
Debt to Total Capital		 0.00% 0.34% 0.00% 0.00% 0.39% 2.44% 63.05% 66.97% 43.09% 40.18% 44.47%
Short-Term Debt to Total Capital		 0.00% 0.34% 0.00% 0.00% 0.39% 2.44% 0.59% 0.07% 0.05% 1.10% 0.94%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 62.46% 66.90% 43.05% 39.09% 43.53%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 13.13% 7.12% 7.71% 4.49% 3.82% 3.90%
Common Equity to Total Capital		 0.00% 99.66% 0.00% 0.00% 99.61% 84.43% 29.84% 25.33% 52.42% 56.00% 51.62%
Debt to EBITDA		 0.00 -0.01 0.00 0.00 34.94 -0.03 -1.14 -1.22 -1.16 -1.05 -1.05
Net Debt to EBITDA		 0.00 0.48 0.00 0.00 -2,325.03 0.46 0.09 -0.04 0.72 0.84 0.56
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 -1.13 -1.22 -1.16 -1.02 -1.03
Debt to NOPAT		 0.00 -0.01 0.00 0.00 0.00 -0.04 -1.75 -1.96 -2.00 -1.86 -1.84
Net Debt to NOPAT		 0.00 0.66 0.00 0.00 0.00 0.66 0.13 -0.06 1.24 1.49 0.97
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 -1.73 -1.96 -2.00 -1.81 -1.80
Altman Z-Score		 0.00 0.00 0.00 0.00 0.00 4.54 2.80 1.37 2.28 4.12 3.89
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 8.85% 19.26% 23.33% 6.55% 8.29% 9.74%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.71 0.00 0.00 1.05 1.85 3.57 4.00 7.55 9.31 7.21
Quick Ratio		 0.00 1.23 0.00 0.00 0.88 1.43 3.31 3.59 7.02 8.87 6.92
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -9.15 -6.75 -15 -20 -20 -18 -21
Operating Cash Flow to CapEx		 0.00% -95.51% -399.10% -857.67% -95.85% -180.27% -238.43% -195.45% -107.93% -284.25% -137.27%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -56.91 -1,119.13 -295.87 -216.23 -207.08 -236.29
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -17.35 -215.44 -74.19 -53.21 -44.21 -36.37
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -26.98 -305.79 -112.15 -102.51 -59.77 -62.87
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.02 0.06 0.08 0.07 0.07 0.06
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.98 8.42
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.22 0.25 0.22
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.24 0.00 0.00 2.05 2.39 1.29
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 40.67 43.34
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 1,530.92 0.00 0.00 178.36 152.99 282.61
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 -1,530.92 0.00 0.00 -178.36 -112.33 -239.27
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 7.46 0.00 0.00 6.39 11 11 15 22 24 26
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.05 0.22 0.30 0.24 0.24 0.23
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 6.39 3.93 11 15 16 12 15
Enterprise Value (EV)		 5.00 0.00 0.00 0.00 0.00 82 202 163 169 299 322
Market Capitalization		 5.00 0.00 0.00 0.00 0.00 87 201 158 185 323 338
Book Value per Share		 $0.00 $0.37 $0.00 $0.00 $0.28 $0.33 $0.22 $0.21 $0.58 $0.67 $0.60
Tangible Book Value per Share		 $0.00 $0.37 $0.00 $0.00 $0.28 $0.27 $0.15 $0.15 $0.53 $0.63 $0.55
Total Capital		 0.00 9.85 0.00 0.00 8.67 19 35 43 74 86 82
Total Debt		 0.00 0.03 0.00 0.00 0.03 0.47 22 29 32 34 37
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 22 29 32 33 36
Net Debt		 0.00 -2.36 0.00 0.00 -2.25 -7.44 -1.67 0.86 -20 -28 -19
Capital Expenditures (CapEx)		 0.00 0.90 0.36 0.15 0.68 1.14 1.25 2.62 4.48 1.32 2.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -0.99 0.00 0.00 -2.13 -2.60 -4.84 -4.17 -2.87 -2.27 -4.35
Debt-free Net Working Capital (DFNWC)		 0.00 1.40 0.00 0.00 0.16 5.31 19 24 49 60 52
Net Working Capital (NWC)		 0.00 1.37 0.00 0.00 0.13 4.84 19 24 49 59 51
Net Nonoperating Expense (NNE)		 2.54 0.00 1.01 1.24 1.46 1.35 2.89 3.66 3.55 3.87 2.89
Net Nonoperating Obligations (NNO)		 0.00 -2.36 0.00 0.00 -2.25 -7.44 -1.67 0.86 -20 -28 -19
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.02 0.02 0.00 0.04 0.20 0.15 0.18 0.05 0.15
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% -600.77% -380.09% -181.67% -84.97% -54.67% -98.71%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 1,225.49% 1,496.08% 1,049.44% 1,439.29% 1,438.74% 1,171.66%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 1,116.86% 1,479.86% 1,048.06% 1,438.31% 1,416.08% 1,154.07%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.14) $0.00 $0.00 $0.00 ($0.12) $0.00 ($0.12)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 26.79M 0.00 0.00 48.77M 33.07M 51.76M 66.69M 61.53M 55.67M 69.48M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.14) $0.00 $0.00 $0.00 ($0.12) $0.00 ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 26.79M 0.00 0.00 48.77M 33.07M 51.76M 66.69M 61.53M 55.67M 69.48M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.14) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 26.79M 0.00 0.00 31.15M 33.07M 44.56M 49.14M 71.39M 72.07M 75.06M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.37 0.00 -2.61 -3.04 -2.76 -2.82 -4.07 -5.22 -3.80 -5.35 -5.57
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -650.35% -484.36% -510.64% -349.69% -448.41% -505.32%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% -964.46% -834.47% -867.42% -677.01% -759.49% -774.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -34.26 -508.48 -128.00 -86.57 -112.46 -102.80
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -23.76 -295.21 -75.57 -41.81 -62.96 -63.87
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -43.89 -598.83 -165.96 -135.87 -128.02 -129.29
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 -33.38 -385.57 -113.53 -91.11 -78.51 -90.37
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -29.63% 0.00% 0.00% 0.00% -3.46% 0.00% -0.24% -8.22% -11.25% 0.00%

Key Financial Trends

ASP Isotopes (NASDAQ:ASPI) Financial Analysis - Last Four Years Overview

ASP Isotopes has shown consistent challenges with profitability, as indicated by continual net losses each quarter over the past four years. Below are the key points from the financial statements analysis:

  • The company maintains a strong cash position with $55.97 million in cash and equivalents as of Q1 2025, which supports liquidity and operational needs.
  • Equity has grown from approximately $8.6 million in Q3 2023 to about $42.5 million by Q1 2025, indicating capital infusion and retention of funds to strengthen the balance sheet.
  • There is continuous investment in property, plant, and equipment, rising from $8.3 million in Q3 2023 to $25.4 million in Q1 2025, showing the company is expanding or upgrading its production capabilities.
  • Operating revenues have increased steadily from zero in early 2023 to over $1.1 million in Q1 2025, suggesting gradual revenue growth, though still modest relative to expenses.
  • Research & Development expenses remain a significant line item, indicating ongoing product development efforts critical to a technology-based business like ASP Isotopes.
  • The weighted average shares outstanding have increased due to equity issuances, which has diluted earnings per share but provided needed capital.
  • The company has reported net losses each quarter, with the most recent net loss at approximately $8.5 million in Q1 2025, which highlights ongoing profitability challenges.
  • Operating expenses vastly exceed operating revenue, driven heavily by selling, general & admin (SG&A) costs, which were about $6.7 million in Q1 2025 compared to just $1.1 million in revenue.
  • Negative cash flow from operating activities has been consistent, showing the company is still burning cash in day-to-day operations (e.g., -$3.2 million in Q1 2025).
  • The company carries a significant debt load with long-term debt around $35.9 million in Q1 2025, which may pressure cash flows and financial flexibility going forward.

Overall, ASP Isotopes is in a growth and investment phase, consistently funding operations and asset expansion through equity and debt issuance. However, persistent net losses and negative operational cash flow present risks. Investors should weigh the company's growth potential in isotope production and technology development against its financial challenges and uncertain path to profitability.

08/24/25 04:03 AMAI Generated. May Contain Errors.

Frequently Asked Questions About ASP Isotopes' Financials

When does ASP Isotopes' fiscal year end?

According to the most recent income statement we have on file, ASP Isotopes' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ASP Isotopes' net income changed over the last 2 years?

ASP Isotopes' net income appears to be on an upward trend, with a most recent value of -$32.42 million in 2024, rising from -$4.95 million in 2022. The previous period was -$16.29 million in 2023. View ASP Isotopes' forecast to see where analysts expect ASP Isotopes to go next.

What is ASP Isotopes' operating income?
ASP Isotopes' total operating income in 2024 was -$26.35 million, based on the following breakdown:
  • Total Gross Profit: $1.60 million
  • Total Operating Expenses: $27.95 million
How has ASP Isotopes' revenue changed over the last 2 years?

Over the last 2 years, ASP Isotopes' total revenue changed from $0.00 in 2022 to $4.14 million in 2024, a change of 414,422,600.0%.

How much debt does ASP Isotopes have?

ASP Isotopes' total liabilities were at $43.18 million at the end of 2024, a 395.7% increase from 2023, and a 1,512.0% increase since 2022.

How much cash does ASP Isotopes have?

In the past 2 years, ASP Isotopes' cash and equivalents has ranged from $2.39 million in 2022 to $61.89 million in 2024, and is currently $61.89 million as of their latest financial filing in 2024.

How has ASP Isotopes' book value per share changed over the last 2 years?

Over the last 2 years, ASP Isotopes' book value per share changed from 0.37 in 2022 to 0.67 in 2024, a change of 83.1%.


Related Companies

This page (NASDAQ:ASPI) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners
Nations are at war over what’s in this box
A resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...
Behind the Markets | Sponsoredtc pixel
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsoredtc pixel
Trump’s “new dollar” could shock Americans
"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...
Stansberry Research | Sponsoredtc pixel
Here's the last trade you should make before heading out for the weekend tomorrow.
On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...
Timothy Sykes | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...
True Market Insiders | Sponsoredtc pixel
Cover all your expenses with just $118,000 invested?
Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...
Investors Alley | Sponsoredtc pixel